CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Defective N-glycosylation in tumor-infiltrating CD8(+) T cells impairs IFN-γ-mediated effector function.
Defective N-glycosylation in tumor-infiltrating CD8(+) T cells impairs IFN-γ-mediated effector function.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
T细胞介导的抗肿瘤免疫部分受N-糖基化调节。然而,N-糖基化与耗竭T细胞效应功能丧失之间的相互作用尚未得到充分研究。本研究在小鼠结肠腺癌模型中阐明N-糖基化对TIL(肿瘤浸润淋巴细胞)耗竭的影响,重点关注IFN-γ介导的免疫应答。研究发现,耗竭CD8⁺ T细胞下调了寡糖基转移酶复合物;该复合物对于转移N-聚糖不可或缺。TIL(肿瘤浸润淋巴细胞)中N-糖基化不足与抗肿瘤免疫丧失相关。补充寡糖基转移酶复合物可恢复IFN-γ产生并缓解CD8⁺ T细胞耗竭,从而减少肿瘤生长。因此,肿瘤微环境中诱发的异常糖基化会使效应CD8⁺ T细胞失去功能。本研究将N-糖基化纳入对IFN-γ这一特征性功能缺失的理解,为阐释CD8⁺ T细胞耗竭提供了新见解,并为在癌症免疫治疗中调节糖基化状态开辟了新机会。
T cell-mediated antitumor immunity is modulated, in part, by N-glycosylation.
However, the interplay between N-glycosylation and the loss of effector function in exhausted T cells has not yet been fully investigated.
Here, we delineated the impact of N-glycosylation on the exhaustion of tumor-infiltrating lymphocytes in a murine colon adenocarcinoma model, focusing on the IFN-γ-mediated immune response.
We found that exhausted CD8 + T cells downregulated the oligosaccharyltransferase complex, which is indispensable for N-glycan transfer. Concordant N-glycosylation deficiency in tumor-infiltrating lymphocytes leads to loss of antitumor immunity. Complementing the oligosaccharyltransferase complex restored IFN-γ production and alleviated CD8 + T cell exhaustion, resulting in reduced tumor growth.
Thus, aberrant glycosylation induced in the tumor microenvironment incapacitates effector CD8 + T cells.
Our findings provide insights into CD8 + T cell exhaustion by incorporating N-glycosylation to understand the characteristic loss of IFN-γ, opening new opportunities to amend the glycosylation status in cancer immunotherapies.
MEMBER ACCOUNT
登录成功会直接打开下一页。